Background Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that
dramatically spread all over the world in the early part of 2020. No studies have yet …

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

We welcome the report by the SPIROMICS investigators in The Lancet Respiratory
Medicine, 1 repeating our 2010 ECLIPSE analysis2 describing exacerbations in chronic …

Large numbers of people are being discharged from hospital following COVID-19 without
assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a …

Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves
outcomes; however, responses to treatment are variable, and patients with COPD often …

Objective Patients with COPD are at risk for cardiovascular events. This is attributed to
increased systemic inflammation. The course of COPD is punctuated by exacerbations …

Impact: This study explores the use of measuring plasma biomarkers at exacerbation of
chronic obstructive pulmonary disease (COPD), providing insight into the underlying …

Rationale: Frequent chronic obstructive pulmonary disease (COPD) exacerbations are a
major cause of hospital admission and mortality and are associated with increased airway …